Medical Weight Loss for Keene, New Hampshire Residents

Keene, New Hampshire residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Keene through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Two GLP-1 options, shipped to Keene: compounded semaglutide shares its active ingredient with Wegovy and Ozempic, and tirzepatide with Mounjaro and Zepbound. These are not FDA-approved and not brand-identical; Dr. Sharma helps New Hampshire patients choose. Doctor review just $119 (medication separate).

Why Keene Residents Choose New Hope Weight Loss

You never have to leave Keene to work with us. The entire program runs by telehealth from our clinic in Costa Mesa, California, so your consultation, your follow-ups, and your dose adjustments all happen by video and message from wherever you are in New Hampshire. Whether you live near downtown Keene and the Monadnock region of southwestern New Hampshire or further out, the care is identical. No commute, no waiting room, no rearranging your week around an appointment across town.

If you are searching for medical weight loss in Keene, New Hope Weight Loss treats patients statewide by telehealth from our Costa Mesa, California clinic. Dr. Sharma reviews your history by secure video and, if appropriate, prescribes compounded semaglutide or tirzepatide shipped to you.

Living in Keene, New Hampshire means your weight-loss care comes to you online rather than the other way around, with Dr. Anjmun Sharma supervising each step from our Costa Mesa practice. We care for patients throughout downtown Keene and the Monadnock region of southwestern New Hampshire. Follow-up check-ins are handled remotely, so adjusting your dose is simple whether you live near downtown Keene or out toward downtown Keene and the Monadnock region of southwestern New Hampshire.

Distance simply stops mattering here, since every appointment for Keene residents takes place over secure video rather than in a waiting room. We accept HSA and FSA cards for the $119 physician review, which lets many Keene patients use pre-tax dollars toward their care. New Hope Weight Loss reaches patients all across New Hampshire by secure telehealth from our Costa Mesa, California clinic, delivering physician-supervised care without any travel.

GLP-1 Weight Loss Programs Available

Begin your reset: semaglutide, from $166/mo

The 90-Day Metabolic Reset gives Keene patients a structured three-month plan with semaglutide, the active ingredient shared with Wegovy and Ozempic. Choose $166 a month or $499 for the whole 90 days. In trials of the branded drug, the average was around 15 to 17 percent body-weight loss. Compounded semaglutide is not FDA-approved and not brand-identical, and results vary.

Go further: tirzepatide, from $233/mo

Tirzepatide hits both GLP-1 and GIP receptors for a dual effect. Qualifying doses in branded-drug trials reached up to 22.5 percent loss, which is not what most patients should expect. It carries the same active ingredient as Mounjaro and Zepbound.

Each plan begins with a $119 physician review. Medication is billed separately. HSA, FSA, Klarna, and Affirm accepted.

How Telehealth Works for Keene

The path from curious to treated is short, and it all runs through your screen. People in Keene start by completing a health-and-weight intake quiz online. Dr. Anjmun Sharma reviews every answer and meets you over secure video, usually within 48 hours, to talk through whether a compounded GLP-1 like semaglutide or tirzepatide fits your goals and history. When she prescribes, a state-licensed 503(a) pharmacy ships the medication to your Keene home in cold-pack packaging designed to keep it stable. After that, you and Dr. Sharma stay connected through video follow-ups, so your progress is supported from any corner of .

Frequently Asked Questions, Keene

Where is the New Hope Weight Loss location serving Keene?

The location serving Keene is our Costa Mesa, California clinic, which is our only physical site. We care for Keene, New Hampshire patients through telehealth rather than a local office. Dr. Anjmun Sharma confirms your eligibility for a compounded GLP-1 plan during a private video consult.

Is remote care a real option for Keene patients?

It is the standard for Keene. The whole program runs on telehealth, so consults, follow-ups, and support happen wherever you are. When Dr. Sharma approves you, compounded medication ships to Keene in cold-pack packaging engineered to keep it at a safe temperature in transit.

How much does a Keene patient pay overall?

The physician review is $119. Compounded semaglutide is offered from $166 monthly, or $499 for 90 days, and tirzepatide from $233 monthly. The medication is billed separately from the visit. We accept HSA, FSA, Klarna, and Affirm, and we apply no distance surcharge for Keene patients.

What areas of Keene do you serve?

We serve patients from across Keene by telehealth, including downtown Keene and the Monadnock region of southwestern New Hampshire.

What support is there for side effects for Keene patients?

Dr. Sharma starts Keene patients at a low dose and titrates slowly to limit nausea and GI effects, and your health advisor is reachable between visits by phone, WhatsApp, or message to adjust the plan if needed.

Keene Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Keene, New Hampshire by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.